York Bridge Wealth Partners, LLC Ironwood Pharmaceuticals Inc Transaction History

York Bridge Wealth Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$11.83 - $16.2 $31,172 - $42,687	-2,635 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $4,285 - $5,247	385 Added 17.11%	2,635 $45,000
Q4 2017 Feb 12, 2018	BUY	$12.16 - $14.58 $11,552 - $13,851	950 Added 73.08%	2,250 $30,000
Q3 2017 Oct 27, 2017	BUY	$12.07 - $14.87 $15,691 - $19,331	1,300	1,300 $21,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.